MARKET

TXMD

TXMD

TherapeuticsMD
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7200
+0.0040
+0.56%
Closed 19:06 09/24 EDT
OPEN
0.7165
PREV CLOSE
0.7160
HIGH
0.7389
LOW
0.7150
VOLUME
3.75M
TURNOVER
--
52 WEEK HIGH
2.750
52 WEEK LOW
0.6700
MARKET CAP
305.15M
P/E (TTM)
-1.4751
1D
5D
1M
3M
1Y
5Y
TherapeuticsMD US Patent & Trademark Office Doc Shows Patent Granted For Co.'s 'Soluble estradiol capsule for vaginal insertion'
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6637&f=G&l=50&d=PTXT&p=133&S1=20210921&OS=20210921&RS=20210921
Benzinga · 5d ago
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors
marketwatch.com · 09/03 21:26
TherapeuticsMD Inc. stock rises Thursday, outperforms market
marketwatch.com · 09/02 21:26
Therapeutics MD Is Urging Women to ‘Take Pause’ During Menopause Awareness Month
BOCA RATON, Fla., September 02, 2021--This September, TherapeuticsMD, Inc., an innovative women’s healthcare company (NASDAQ: TXMD), is recognizing Menopause Awareness Month, as it aims to empower the 64 million women in the U.S. currently in menopauseii. ...
Business Wire · 09/02 10:50
TherapeuticsMD Inc. stock falls Wednesday, underperforms market
marketwatch.com · 09/01 21:26
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors
marketwatch.com · 08/30 21:26
TherapeuticsMD Inc. stock rises Friday, still underperforms market
marketwatch.com · 08/27 21:26
TherapeuticsMD Inc. stock rises Wednesday, outperforms market
marketwatch.com · 08/25 21:26
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TXMD. Analyze the recent business situations of TherapeuticsMD through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TXMD stock price target is 5.80 with a high estimate of 10.00 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 241
Institutional Holdings: 185.94M
% Owned: 43.87%
Shares Outstanding: 423.82M
TypeInstitutionsShares
Increased
48
11.52M
New
17
1.26M
Decreased
38
12.82M
Sold Out
24
5.45M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.45%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Non-Executive Chairman/Independent Director
Thomas Thompson
President
Hugh O Dowd
Chief Executive Officer/Director
Robert Finizio
Chief Financial Officer
James D'Arecca
Executive Vice President
Edward Borkowski
Vice President - Finance
Michael Donegan
General Counsel
Marlan Walker
Secretary
John Milligan
Independent Director
Paul Bisaro
Independent Director
J. Martin Carroll
Independent Director
Cooper Collins
Independent Director
Karen Ling
Independent Director
Jules Musing
Independent Director
Gail Naughton
Independent Director
Angus Russell
No Data
About TXMD
TherapeuticsMD, Inc. is a women's healthcare company engaged in creating and commercializing products for women. The Company is focused on pursuing regulatory approvals and pre-commercialization activities necessary for commercialization of its hormone therapy pharmaceutical products. Its drug candidates used in clinical trials are designed to alleviate symptoms of and reduce health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis and vaginal discomfort. With its SYMBODA technology, it is developing hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through dosage forms and administration routes. Its product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.

Webull offers kinds of TherapeuticsMD Inc stock information, including NASDAQ:TXMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TXMD stock methods without spending real money on the virtual paper trading platform.